Wirksamkeit, Verträglichkeit und Sicherheit von medizinischem Cannabis-Reference-Cited by-同舟云学术

Wirksamkeit, Verträglichkeit und Sicherheit von medizinischem Cannabis

Published:2019 Issue: Volume: Page:265-426
ISSN:
Container-title:Cannabis: Potenzial und Risiko
language:
Short-container-title:

Author:

Hoch Eva,Schneider Miriam,von Keller Rupert,Bonnet Udo,Falkai Peter,Hasan Alkomiet,Häuser Winfried,Hinz Burkhard,Jakob Luise,Kabisch Johannes,Kraus Ludwig,Niemann Dominik,Petzke Frank,Pogarell Oliver,Preuss Ulrich,Radbruch Lukas,Sarubin Nina,Schacherbauer Kathrin,Schäfer Michael,Storr Martin,Friemel Chris Maria

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-662-57291-7_4

Reference272 articles.

1. Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S (2007) Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology 68 (7): 515–521

2. Andreae MH, Carter GM, Shaparin N, Suslov K, Ellis RJ, Ware MA, Abrams DI, Prasad H, Wilsey B, Indyk D, Johnson M, Sacks HS (2015) Inhaled cannabis for chronic neuropathic pain: a meta-analysis of individual patient data. J Pain 16 (12): 1221–1232. doi: 10.1016/j.jpain.2015.07.009

3. Berman JS, Symonds C, Birch R (2004) Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial. Pain 112: 299–306

4. Blake DR, Robson P, Ho M, Jubb RW, McCabe CS (2006) Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology (Oxford) 45 (1): 50–52

5. Bonica JJ (2001) Bonica’s management of pain. Lippincott Williams & Wilkins, Philadelphia

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nabiximols in Chronic Neuropathic Pain: A Meta-Analysis of Randomized Placebo-Controlled Trials;Pain Medicine;2021-02-09

2. The Use of Alcohol, Tobacco, Illegal Drugs and Medicines;Deutsches Ärzteblatt international;2019-09-02